IIH Biomarker Study
Determining when a patient with IIH requires urgent intervention to preserve vision varies widely across centres internationally, as there are currently no universally accepted criteria or thresholds.
If intervention is delayed, irreversible visual loss may occur, with profound long term consequences for patients’ quality of life. Conversely, if performed too early, patients may be exposed to unnecessary procedural risks, including significant complications and the potential need for revision procedures.
There is therefore a critical need for reliable biomarkers to identify sight-threatening IIH and support timely clinical decision making. Our research is focused on evaluating optical coherence tomography (OCT) biomarkers and biofluid biomarkers in IIH, with the aim of improving risk stratification and guiding more precise, evidence-based intervention.
Led by PhD Candidate Dr Jessie Gew